APOL1遺伝子と腎臓移植:レビュー記事

Melissa Gaspar Tavares¹, Lúcio Requião-Moura¹, Luísa Queiroga¹

¹Universidade Federal de São Paulo, Hospital do Rim, Divisão de Nefrologia, São Paulo, SP, Brasil.

Jornal brasileiro de nefrologia

|February 19, 2026

まとめ

APOL1遺伝子変異は慢性腎臓病 (CKD) と関連しており,腎臓移植の結果にも影響している. ドナーのこれらのリスク変種に関する研究は,長期の移植生存を改善するために不可欠です.

科学分野:

ネフロロジーはネフロロジーを用います.
遺伝学遺伝学とは
移植免疫学移植免疫学

背景:

慢性腎臓病 (CKD) は,世界的な健康問題である.
腎臓移植は,末期腎疾患 (ESRD) の最良の治療法です.
APOL1遺伝子変異は,CKDの進行と移植の結果の要因としてますます認識されています.

研究の目的:

腎臓移植の結果に対するAPOL1遺伝子変異の影響を調査する.
APOL1リスク変異の役割を,既死者と生きている腎臓ドナーにおいて評価する.
APOL1.1に関連する潜在的な治療目標を探求する.

主な方法:

CKD.に関連したAPOL1遺伝子変異 (G1およびG2) の分析.
ドナーのAPOL1状態に基づいて腎臓移植の生存に関する証拠のレビュー.
APOL1および関連する分子を分析するタンパク質学的研究の探索.

主要な成果:

APOL1リスク変種 (G1,G2) は,CKDと関連しています.
APOL1リスク変異を持つ死去したドナーの腎臓は,移植後の生存率が低下しています.
生きているドナーにおけるAPOL1リスク変異は,ドナー後の長期的に悪い結果と関連しています.

結論:

APOL1のリスク変異は,CKDと腎臓移植の理解に大きな影響を与えます.
生きているドナーにおけるAPOL1変異のさらなる研究は,ドナーの選択を最適化することができます.
APOL1の機能を標的とする新しい治療法は,今後の治療法を提供する可能性があるが,まだ移植受容者に試験されていない.

さらに関連する動画

09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

09:00

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients

Published on: April 13, 2021

関連する概念動画

01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...

01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...

01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...

01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...

関連する実験動画